Use of artemisia annua extract in the preparation of a medicine for preventing and treating plant pathogenic fungi

The preparation method of Artemisia annua extract has solved the problems of drug resistance and environmental pollution of chemical fungicides in agriculture, and has achieved effective inhibition of various plant pathogenic fungi and reduction of DON toxin, showing potential for green and low-cost application.

CN123100670APending Publication Date: 2026-11-17INST OF BOTANY CHINESE ACAD OF SCI +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611382109.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-08
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing chemical fungicides are prone to developing resistance, pesticide residues, and environmental pollution with long-term use in agriculture, and are difficult to effectively control plant pathogenic fungi such as Fusarium graminearum and cucumber powdery mildew.

Method used

Artemisia annua extract was used to prepare a formulation containing Artemisia annua extract by light-protected ethanol-water extraction and ultrasonic extraction, combined with vacuum concentration. This formulation is used to prepare an antibacterial agent to achieve antibacterial effect by contacting plant pathogenic fungi.

Benefits of technology

Artemisia annua extract exhibits strong inhibitory effects on various plant pathogenic fungi, reduces the DON toxin content produced by Fusarium graminearum, and has a significant control effect on cucumber powdery mildew. It is green, safe, environmentally friendly, and inexpensive, making it suitable for large-scale production.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123100670A_ABST
    Figure CN123100670A_ABST
Patent Text Reader

Abstract

This invention relates to the field of plant fungicide technology, and particularly to the use of Artemisia annua extract or drugs containing Artemisia annua extract in the preparation of products for controlling plant pathogenic fungi. The Artemisia annua extract is obtained by pulverizing Artemisia annua, adding it to an ethanol-water solution for extraction in the dark, followed by ultrasonic extraction, solid-liquid separation, and concentration of the resulting extract. The plant pathogenic fungi are Fusarium graminearum, Fusarium oxysporum, Sclerotium sclerotiorum, Rhizoctonia solani, Erythrina variegata, Colletotrichum candida, Colletotrichum candida, Ulva globosum, Dikaryotic Rhizoctonia solani fusion group AG-P, Polychaete chamomile, Curvularia, Cercospora, Fusarium cladoides, and Subsp. spp. Didymellasegeticola At least one of the following. This invention also discloses that Artemisia annua extract can reduce the content of deoxynivalenol in Fusarium graminearum culture systems.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of plant fungicide technology, and in particular to the application of Artemisia annua extract in the preparation of drugs for the prevention and control of plant pathogenic fungi. Background Technology

[0002] Plant pathogens are one of the major biological disasters that restrict stable agricultural production and increased income. Pathogenic fungi that are prevalent in the field, such as Fusarium graminearum and Fusarium oxysporum, can cause a variety of major diseases such as wheat scab and crop wilt, which can cause crop yield reduction of 15-40% every year. In severely affected fields, the crop may even be completely destroyed. At the same time, they can also lead to the accumulation of pathogen toxins, which affect the quality and safety of agricultural products.

[0003] Currently, chemical fungicides remain the primary treatment for these diseases in agricultural production. Long-term, large-scale, and singular application of chemical pesticides easily leads to a series of problems, including increased pathogen resistance, excessive pesticide residues, soil and water pollution, and damage to non-target organisms, contradicting the development concepts of green and ecological agriculture. Therefore, developing highly efficient, low-toxicity, residue-free, and environmentally friendly plant-derived biological pesticides to replace or reduce the use of chemical pesticides has become a core research direction in the field of plant disease control.

[0004] Fusarium head blight, caused by Fusarium, is one of the most serious fungal diseases affecting major grain crops such as wheat, barley, and corn in my country and even worldwide. It not only leads to a significant drop in yield but also seriously threatens food safety and human and animal health due to the deoxynivalenol (DON, also known as vomitoxin, a type B trichothecene toxin and one of the most common toxins contaminating grains) produced by the pathogen. DON toxins are chemically stable and difficult to completely remove through conventional food processing and cooking methods. Once it enters the food chain through grains and their products, it can cause acute or chronic poisoning reactions in humans and animals, such as nausea, vomiting, diarrhea, and immunosuppression. Long-term exposure may also interfere with endocrine and nervous system development.

[0005] In recent years, influenced by factors such as climate warming, straw return to the field cultivation model, and the large planting area of ​​susceptible varieties, Fusarium head blight has become increasingly prevalent in major grain-producing areas such as the Huang-Huai-Hai Plain and the middle and lower reaches of the Yangtze River. The problem of excessive DON toxin levels is becoming increasingly prominent, posing a severe challenge to grain storage, processing, and trade. Therefore, it is necessary to systematically conduct research on Fusarium head blight control and toxin reduction technologies to effectively reduce DON toxin contamination levels.

[0006] Cucumber powdery mildew is caused by the obligate parasitic fungus *Erysiphe spp.* (Cucurbitaceae family). Erysiphe cucurbitacearumPowdery mildew is a global airborne disease caused by fungicides. It primarily affects leaves, but can also infect petioles and stems. In the early stages, nearly circular white powdery spots appear on the upper surface of the leaves, gradually expanding and merging. In severe cases, the entire leaf is covered with a white powdery layer, leading to chlorophyll decomposition, decreased photosynthetic efficiency, and premature yellowing and leaf drop. Powdery mildew is highly prevalent under warm (20-25℃) and alternating dry and humid conditions, and is particularly severe in greenhouse and polytunnel cultivation. It generally causes a 20-30% yield reduction, with severely affected fields experiencing reductions of over 50%, while also impacting cucumber quality and marketability. Currently, production mainly relies on chemical fungicides such as triazoles and pyraclostrobin, but long-term use can lead to resistance and poses a risk of pesticide residues. Therefore, developing highly efficient, low-toxicity, and environmentally friendly plant-derived extracts or natural monomeric components has become an important research direction for the green control of cucumber powdery mildew.

[0007] Artemisia annua ( Artemisia annua Artemisia annua (L.) is an annual herb belonging to the genus Artemisia in the family Asteraceae, and is a traditional Chinese medicinal herb. The entire plant is rich in terpenes, flavonoids, coumarins, and other secondary metabolites, exhibiting broad-spectrum biological activity. Current research has preliminarily confirmed that artemisinin and Artemisia annua extracts possess certain antibacterial activity; however, existing technologies generally suffer from drawbacks such as complex extraction processes, low artemisinin utilization, narrow antibacterial spectrum, and the lack of standardized formulations and field application protocols. A complete technical solution for large-scale production and direct field application is lacking, hindering industrial-scale promotion. Summary of the Invention

[0008] The purpose of this invention is to provide the application of Artemisia annua extract in the preparation of drugs for the prevention and control of plant pathogenic fungi, so as to solve the problems of drug resistance, pesticide residues and environmental pollution caused by long-term use of existing chemical fungicides.

[0009] In a first aspect, the present invention proposes the use of Artemisia annua extract or preparations containing Artemisia annua extract in the preparation of products for the prevention and control of plant pathogenic fungi, wherein the Artemisia annua extract is obtained by pulverizing Artemisia annua, adding it to an aqueous ethanol solution for extraction in the dark, followed by ultrasonic extraction, solid-liquid separation, and concentration of the resulting extract.

[0010] In one embodiment, the plant pathogenic fungus is Fusarium graminearum (Fusarium graminearum). Fusarium graminearum Fusarium oxysporum ( Fusarium oxysporum ), neatly arranged small sclerotia ( Sclerotium rolfsii Rhizoctonia solani ( ) Rhizoctonia solani ), Cucurbitaceae powdery mildew ( Erysiphe cucurbitacearum ), Tea-seat Discocele ( Discula theae-sinensis ), Camellia thorny spores ( Colletotrichum camelliae ), *Ulva globosum* ( Nigrospora sphaerica ), Dinucleotidylcholine ( Binucleate Rhizoctonia ) Fusion group AG-P, Pseudomonas chamois ( Pseudopestalotiopsis theae ), Curvularia (Curvularia Fungi, Cercospora ( Cercospora Fungi, Fusarium moniliforme ( Fusarium concentricum ), Subseptospora genus fungi Didymella segeticola At least one of them.

[0011] In a second aspect, the present invention proposes the use of Artemisia annua extract or preparations containing Artemisia annua extract in the preparation of products that inhibit the production of deoxynivalenol by Fusarium graminearum, wherein the Artemisia annua extract is obtained by pulverizing Artemisia annua, adding it to an aqueous ethanol solution for extraction in the dark, followed by ultrasonic extraction, solid-liquid separation, and concentration of the resulting extract.

[0012] In one embodiment, the Artemisia annua is the above-ground part of Artemisia annua that is free from mold and dried, preferably the stems and leaves of Artemisia annua.

[0013] In one embodiment, the volume fraction of the ethanol-water solution is 70-90%, and the mass-to-volume ratio of the Artemisia annua to the ethanol-water solution is 1 g: 15-25 mL.

[0014] Specifically, the volume fraction of the ethanol-water solution is 75%, and the mass-to-volume ratio of Artemisia annua to the ethanol-water solution is 1 g: 20 mL.

[0015] In one embodiment, the light-protected extraction time is 70-75 h, preferably 72 h.

[0016] In one embodiment, the ultrasonic extraction power is 55-65 W, the ultrasonic extraction time is 25-35 minutes, and the temperature during the ultrasonic extraction process is ≤40℃.

[0017] Specifically, the ultrasonic extraction power is 60 W, and the ultrasonic extraction time is 30 minutes.

[0018] In one embodiment, during the ultrasonic extraction process, the mixture is stirred every 10 minutes to ensure that the material is in uniform contact with the ethanol-water solution.

[0019] In one implementation, the water temperature is monitored in real time during the ultrasonic extraction process, and the process is paused or replaced with ice water if the temperature exceeds 40°C.

[0020] In one embodiment, the solid-liquid separation method is vacuum filtration, that is, collecting the filtrate after vacuum filtration using a Buchner funnel.

[0021] In one implementation, the concentration endpoint is to concentrate to one-fifth to one-sixth of the original volume.

[0022] In one embodiment, the concentration is vacuum concentration; the temperature of the vacuum concentration is 30-40°C; the vacuum degree of the vacuum concentration is -0.08 to -0.09 MPa, preferably -0.085 MPa.

[0023] In one embodiment, the rotary evaporator rotates at 60-80 rpm during the vacuum concentration process.

[0024] In one embodiment, the artemisinin content in the Artemisia annua extract is 0.1-0.15% by mass, preferably 0.12%.

[0025] In one embodiment, the formulation containing Artemisia annua extract comprises Artemisia annua extract and a pharmaceutically acceptable carrier.

[0026] Specifically, the preparation containing Artemisia annua extract also includes surfactants.

[0027] Preferably, the surfactant has a mass percentage content of 0.1%.

[0028] Preferably, the surfactant is Tween-80.

[0029] In one embodiment, the dosage form of the preparation containing Artemisia annua extract includes, but is not limited to, sustained-release formulations, aqueous solutions, suspensions, emulsions, tablets, powders, granules, and effervescent tablets.

[0030] In one embodiment, the product includes, but is not limited to, pesticides, agricultural machinery, and pesticide-machinery combinations.

[0031] In a third aspect, the present invention provides a method for inhibiting plant pathogenic fungi by contacting the plant pathogenic fungi with an antibacterial agent containing Artemisia annua extract or an antibacterial agent containing an extract of Artemisia annua.

[0032] In a fourth aspect, the present invention provides a method for inhibiting the production of deoxynivalenol by Fusarium graminearum, wherein an antibacterial agent containing Artemisia annua extract or an antibacterial agent containing Artemisia annua extract is brought into contact with Fusarium graminearum.

[0033] In one embodiment, the Artemisia annua extract is obtained by pulverizing Artemisia annua, adding it to an aqueous ethanol solution for extraction in the dark, followed by ultrasonic extraction, solid-liquid separation, and concentration of the resulting extract.

[0034] In one embodiment, the Artemisia annua is the above-ground part of Artemisia annua that is free from mold and dried, preferably the stems and leaves of Artemisia annua.

[0035] In one embodiment, the volume fraction of the ethanol-water solution is 70-90%, and the mass-to-volume ratio of the Artemisia annua to the ethanol-water solution is 1 g: 15-25 mL.

[0036] Specifically, the volume fraction of the ethanol-water solution is 75%, and the mass-to-volume ratio of Artemisia annua to the ethanol-water solution is 1 g: 20 mL.

[0037] In one embodiment, the light-protected extraction time is 70-75 h, preferably 72 h.

[0038] In one embodiment, the ultrasonic extraction power is 55-65 W, the ultrasonic extraction time is 25-35 minutes, and the temperature during the ultrasonic extraction process is ≤40℃.

[0039] Specifically, the ultrasonic extraction power is 60W, and the ultrasonic extraction time is 30 minutes.

[0040] In one embodiment, during the ultrasonic extraction process, the mixture is stirred every 10 minutes to ensure that the material is in uniform contact with the ethanol-water solution.

[0041] In one implementation, the water temperature is monitored in real time during the ultrasonic extraction process, and the process is paused or replaced with ice water if the temperature exceeds 40°C.

[0042] In one embodiment, the solid-liquid separation method is vacuum filtration, that is, collecting the filtrate after vacuum filtration using a Buchner funnel.

[0043] In one implementation, the concentration endpoint is to concentrate to one-fifth to one-sixth of the original volume.

[0044] In one embodiment, the concentration is vacuum concentration; the temperature of the vacuum concentration is 30-40°C; the vacuum degree of the vacuum concentration is -0.08 to -0.09 MPa, preferably -0.085 MPa.

[0045] In one embodiment, the rotary evaporator rotates at 60-80 rpm during the vacuum concentration process.

[0046] In one embodiment, the artemisinin content in the Artemisia annua extract is 0.1-0.15% by mass, preferably 0.12%.

[0047] In one embodiment, the formulation containing Artemisia annua extract comprises Artemisia annua extract and a pharmaceutically acceptable carrier.

[0048] Specifically, the preparation containing Artemisia annua extract also includes surfactants.

[0049] Preferably, the surfactant has a mass percentage content of 0.1%.

[0050] Preferably, the surfactant is Tween-80.

[0051] In one embodiment, the dosage form of the preparation containing Artemisia annua extract includes, but is not limited to, sustained-release formulations, aqueous solutions, suspensions, emulsions, tablets, powders, granules, and effervescent tablets.

[0052] In one embodiment, the antibacterial agent is a solution.

[0053] Compared with the prior art, the present invention has the following beneficial effects: (1) Green and safe with good environmental compatibility: Pure plant-derived extract, low toxicity to humans, animals and non-target organisms, no risk of pesticide residue, does not pollute soil or water sources, and is compatible with green food and organic food production standards, solving the problem of chemical pesticide residue and pollution.

[0054] (2) Simple process, low cost and high resource utilization: The extraction process is mild and does not require special equipment. It can be industrialized on a large scale and improve the comprehensive utilization rate of Artemisia annua resources.

[0055] (3) The Artemisia annua extract obtained in this invention exhibits a strong inhibitory effect on a variety of plant pathogenic fungi, and has the core advantage of being developed into a fungicide.

[0056] (4) The Artemisia annua extract obtained in this invention can reduce the DON unit content in the Fusarium graminearum culture system under experimental conditions and shows a certain control effect on cucumber powdery mildew. Attached Figure Description

[0057] Figure 1 This is the equation for the standard curve of artemisinin standard.

[0058] Figure 2 The chromatograms of Artemisia annua extract and artemisinin standards at 200 nm are shown.

[0059] Figure 3 The effects of different concentrations of Artemisia annua extract on the mycelial growth of Fusarium graminearum.

[0060] Figure 4 The effects of different concentrations of Artemisia annua extract on the mycelial growth of Fusarium oxysporum.

[0061] Figure 5 The effect of different concentrations of Artemisia annua extract on the growth of Sclerotium truncatum mycelium.

[0062] Figure 6 The effects of different concentrations of Artemisia annua extract on the mycelial growth of Rhizoctonia solani.

[0063] Figure 7 The effect of different concentrations of Artemisia annua extract on the mycelial growth of Colletotrichum candida.

[0064] Figure 8 The effect of different concentrations of Artemisia annua extract on the mycelial growth of Colletotrichum camelliae.

[0065] Figure 9 The effects of different concentrations of Artemisia annua extract on the mycelial growth of Mycorrhizal globulus.

[0066] Figure 10 The effect of different concentrations of Artemisia annua extract on the mycelial growth of the AG-P fusion group of Rhizoctonia solani.

[0067] Figure 11 The effect of different concentrations of Artemisia annua extract on the mycelial growth of Polychaete chamaejasme.

[0068] Figure 12 Different concentrations of Artemisia annua extract were used to study the effects of Curvularia spp. ( Curvularia The influence of fungal hyphal growth.

[0069] Figure 13 Different concentrations of Artemisia annua extract were used to study the effects of Cercospora spp. ( Cercospora The influence of fungal hyphal growth.

[0070] Figure 14 The effects of different concentrations of Artemisia annua extract on the mycelial growth of Fusarium moniliforme.

[0071] Figure 15 To investigate the effects of different concentrations of Artemisia annua extract on the fungi of the genus Subparis. Didymella segeticola The impact on mycelial growth.

[0072] Figure 16 Phenotypic results show the effects of artemisinin, Artemisia annua extract, and control agents on the control of powdery mildew in cucumbers. Detailed Implementation

[0073] The present invention will now be described in further detail with reference to specific embodiments. The given embodiments are merely illustrative of the invention and not intended to limit its scope. The embodiments provided below can serve as a guide for further improvements by those skilled in the art and do not constitute a limitation on the invention in any way.

[0074] Unless otherwise specified, the experimental methods used in the following examples are conventional methods, performed according to the techniques or conditions described in the literature in this field or according to the product instructions. Unless otherwise specified, the materials and reagents used in the following examples are commercially available.

[0075] Example 1: Preparation of Artemisia annua extract Take 40 g of dried Artemisia annua leaves that are free of mold, crush them and pass them through a 40-mesh standard sieve to obtain Artemisia annua raw material powder.

[0076] According to the ratio of raw material powder to extraction solvent of 1 g: 20 mL, 800 mL of 75% ethanol aqueous solution was added to 40 g of raw material powder of Artemisia annua, mixed evenly, and extracted at room temperature in the dark for 72 h.

[0077] After extraction, place the container holding the extracted material in an ultrasonic cleaner and ultrasonically extract for 30 minutes at 60 W (during ultrasonic extraction, control the water temperature in the ultrasonic cleaner's water bath to not exceed 40℃, and gently shake or mix once every 10 minutes; when the temperature approaches 40℃, pause the ultrasonic extraction or use ice water to cool it down). After ultrasonic extraction, use a Buchner funnel for vacuum filtration and collect the filtrate.

[0078] The filtrate was placed in a rotary evaporator and concentrated under reduced pressure at a water bath temperature of 30–40 °C, a vacuum degree of -0.085 MPa, and a rotary evaporator speed of 60–80 rpm to obtain 160 mL of Artemisia annua extract.

[0079] Artemisinin standard (purchased from Shanghai Yuanye Biotechnology Co., Ltd.) was diluted to prepare a series of concentration gradients (5 mg / mL, 4.5 mg / mL, 4 mg / mL, 3.5 mg / mL, 3 mg / mL, 2.5 mg / mL, 2 mg / mL, 1.5 mg / mL, 1 mg / mL, 0.5 mg / mL), and detected by high performance liquid chromatography. A standard curve for artemisinin content was plotted (y=3045.7x+173.99, R²=0.9988). Figure 1 As shown.

[0080] Based on the artemisinin content standard curve and Figure 2 It is known that the artemisinin content in the Artemisia annua extract obtained in this embodiment is 0.12% (i.e., 0.12 g / 100 mL).

[0081] Example 2: Indoor antibacterial activity determination (mycelial growth rate method) Fusarium graminearum ( Fusarium graminearum Fusarium oxysporum ( Fusarium oxysporum ), neatly arranged small sclerotia ( Sclerotium rolfsii Rhizoctonia solani ( ) Rhizoctonia solani ), Cucurbitaceae powdery mildew ( Erysiphe cucurbitacearum ), Tea-seat Discocele ( Discula theae-sinensis ), Camellia thorny spores ( Colletotrichum camelliae ), *Ulva globosum* ( Nigrospora sphaerica ), Dinucleotidylcholine ( Binucleate Rhizoctonia) Fusion group AG-P, Pseudomonas chamois ( Pseudopestalotiopsis theae ), Curvularia ( Curvularia Fungi, Cercospora ( Cercospora Fungi, Fusarium moniliforme ( Fusarium concentricum ), Subseptospora genus fungi Didymella segeticola The pathogen was tested using PDA medium.

[0082] The Artemisia annua extract obtained in Example 1 was diluted to 100× (approximately 12 ppm based on artemisinin content), 50× (approximately 24 ppm based on artemisinin content), and 10× (approximately 120 ppm based on artemisinin content), respectively.

[0083] Using PDA medium without Artemisia annua extract as a blank control (CK), each treatment was repeated three times and incubated at 28°C. Colony diameter was measured using the cross-hatching method, and inhibition rate and EC were calculated. 50 .

[0084] The measurement results are as follows Figures 3 to 15 As shown in Table 1, Artemisia annua extract (based on artemisinin content) showed an effect on Fusarium graminearum EC. 50 =22.67 ppm, with the highest inhibition rate of 79.58% at 120 ppm; Artemisia annua extract inhibited Fusarium oxysporum EC. 50 =45.74ppm, with an inhibition rate as high as 69.61%; Artemisia annua extract aligns with Sclerotium truncatum EC. 50 =18.23 ppm, with an inhibition rate of up to 100%; Artemisia annua extract inhibited Rhizoctonia solani EC. 50 =50.72 ppm, with an inhibition rate as high as 78.28%. The above results demonstrate that the Artemisia annua extract obtained in Example 1 possesses extremely strong inhibitory activity against pathogenic fungi.

[0085] Table 1. Statistical analysis of the antifungal rates of different dilutions of Artemisia annua extract obtained in Example 1 against plant pathogenic fungi.

[0086] Example 3: The regulatory effects of fungicides with different mechanisms of action on DON toxin (deoxynivalenol) may vary significantly. To scientifically evaluate the effectiveness of novel toxin-controlling substances, this embodiment included two commonly used chemical fungicides (pyraclostrobin and cyazofamid) as controls in the experimental group to compare the effects of the test extract on the growth and toxin production of Fusarium graminearum (i.e., Fusarium graminearum).

[0087] Based on this, this embodiment uses these two chemical fungicides as a reference to evaluate the effectiveness of Artemisia annua extract in inhibiting the growth of Fusarium wilt and reducing DON toxin content. The aim is to clarify whether Artemisia annua extract has the potential to be superior to or supplement existing chemical control strategies, thereby providing a scientific basis for developing green alternatives that take into account both disease prevention and toxin control.

[0088] 1. Sample pretreatment: Add the Artemisia annua extract obtained in Example 1 (diluted 200 times) or chemical agent 1 (pyraclostrobin, concentration EC) to the Fusarium graminearum culture medium. 50 Concentration), Chemical Agent 2 (Cypermethrin, used concentration is EC) 50 After culturing at 27℃ for 7 days (concentration), collect the culture filtrate of Fusarium graminearum, extract twice with ethyl acetate; centrifuge the extract at 2500 r / min for 5 min, and take the supernatant for later use.

[0089] 2. Purification and concentration: Add 25 mg / mL of PSA packing material (N-propylethylenediamine) to the supernatant, vortex for 3 min, centrifuge and collect the supernatant; after drying with nitrogen or by natural blowing, add 100 μL of chromatographic grade methanol to reconstitute.

[0090] 3. Instrument detection: The reconstituted solution was filtered through a 0.22 μm organic filter membrane, and the filtrate was collected into a liquid chromatography vial. The DON toxin content was determined by high performance liquid chromatography (HPLC). The DON unit content is expressed as μg / g.

[0091] Chromatographic analysis: (1) Instruments and chromatographic conditions: 10 µL of the test solution was injected into the high performance liquid chromatography system, which was equipped with a 1260 Infinity quaternary pump, a 1260 Infinity UV detector and an Agilent Zorbax Eclipse XDB-C18 column (4.6×150 mm, 5 µm); the column temperature was 30℃ and the flow rate was 1 mL / min.

[0092] (2) Gradient elution program: The mobile phase is methanol-water, and linear gradient elution is adopted: the methanol ratio increases from 25% to 75% within 15 min, then increases to 80% within 5 min and maintains it for 3 min, and then decreases back to 25% within 3 min and maintains it for 3 min.

[0093] (3) Detection and data analysis: The ultraviolet detection wavelength was 218 nm, which was used to determine DON toxin; the method was performed and the results were analyzed using Agilent ChemStation software (B.04.03) (Agilent Technologies, Santa Clara, California, USA); three biological replicates were set up for each treatment.

[0094] Table 2 Comparison of the inhibitory effects of Artemisia annua extract and control agents on DON toxin (vomiting toxin).

[0095] The above results demonstrate that the Artemisia annua extract obtained in Example 1 not only exhibits significant detoxification properties against DON toxin, but its detoxification effect is also significantly superior to that of pyraclostrobin and cyazofamid. More importantly, this Artemisia annua extract is derived from natural plant resources, is easily degraded in the environment, and leaves no harmful residues, aligning with the development concept of green pesticides. As a highly efficient, green, and safe detoxification candidate, Artemisia annua extract has broad application prospects as a substitute for or supplement to existing chemical control strategies.

[0096] Example 4: 4.1 Experimental Materials: (1) Test plant: cucumber ( Cucumis sativus The selected cucumber variety, Changchun Mici, is susceptible to powdery mildew. Cucumber seeds were sown in 10cm seedling pots with a substrate of sterilized garden soil: peat moss: vermiculite = 2:1:1. The pots were then cultured in an artificial climate chamber or greenhouse (25±2℃, 12h light / 12h dark, relative humidity 60-70%). Seedlings were tested when they reached the 2-3 true leaf stage (approximately 3-4 weeks).

[0097] (2) Test pathogen: Powdery mildew (Cucurbitaceae family) Erysiphe cucurbitacearum Fresh diseased leaves were collected from typical diseased cucumber plants in the field and propagated and preserved on live cucumber seedlings in a greenhouse. Before inoculation, conidia were washed away with sterile water, filtered through double-layered gauze, and the spore suspension concentration was adjusted to 1×10⁻⁶ using a hemocytometer. 5 pcs / mL (containing 0.1% Tween-80).

[0098] (3) Test reagents: 1) Artemisia annua extract: The Artemisia annua extract obtained in Example 1 was used as the stock solution and was serially diluted with distilled water (containing 0.1% Tween-80) to 10%, 1%, 0.3%, 0.2% and 0.1% (volume ratio).

[0099] 2) Artemisinin monomer: Weigh the artemisinin standard, dissolve it in a small amount of ethanol (≤1%), and then dilute it with distilled water (containing 0.1% Tween-80) to prepare solutions with concentrations of 10 mg / L (10 ppm), 100 mg / L (100 ppm) and 500 mg / L (500 ppm).

[0100] 3) Positive control agent: 18% D-limonene soluble concentrate. Dosage: 30 mL / mu. For conventional spraying, use 45 L of water per mu, with a dilution ratio of approximately 1500 times. In pot experiments, prepare the solution according to this dilution ratio (i.e., take 1 part of 18% limonene, add 1499 parts of water, and add 0.1% Tween-80).

[0101] (4) Negative control: water (containing 0.1% Tween-80).

[0102] 4.2 Experimental Design: (1) The groups are as follows: Artemisia annua extract treatment: 5 concentrations (10%, 1%, 0.3%, 0.2%, 0.1%); Artemisinin monomer treatment: 3 concentrations (10 ppm, 100 ppm, 500 ppm); Positive control: 18% D-limonene 1500 times solution; Negative control: water (0.1% Tween-80).

[0103] (2) Replication and sample size: Each treatment was replicated 3 times (i.e., 3 pots), with 1 cucumber seedling planted in each pot.

[0104] 4.3 Experimental Procedure: (1) Select cucumber seedlings with uniform growth and 2-3 true leaves, and spray the leaves of each treatment according to the experimental design. Use a handheld sprayer to spray the front and back of the leaves evenly until the liquid is about to drip.

[0105] (2) 24 hours after spraying, use freshly prepared powdery mildew spore suspension (1×10⁻⁶) 5 Inoculate all leaves evenly with a spray of (number per mL).

[0106] (3) Immediately after inoculation, cover the container with a transparent plastic bag to keep it moist for 24-48 hours (temperature 22-25℃). After that, remove the plastic bag and place it in a greenhouse for routine management (temperature 22-25℃, relative humidity 70-80%, natural light).

[0107] (4) 7-10 days after inoculation, when the diseased control plants in the water are fully infected (the diseased leaf rate reaches more than 80%), investigate the disease status of all leaves according to the disease grading standard.

[0108] 4.4 The disease severity classification is shown in Table 3.

[0109] Table 3 Disease Classification

[0110] 4.5 Data Survey and Prevention Efficacy Calculation (1) Disease index ( DI )calculate .

[0111] (2) Prevention and control effect ( CE )calculate .

[0112] 4.6 Based on the results of the pot experiment (the disease index and control effect were calculated using a seven-level grading method of 0, 1, 3, 5, 7, 9, and 11), water was used as the negative control (CK disease index 46.97), and 18% D-limonene (30 mL / mu, diluted approximately 1500 times) was used as the positive control (control efficacy 62.90%). The control effects of each treatment on cucumber powdery mildew are shown in Table 4 and... Figure 16 As shown.

[0113] Table 4. Comparison of the control effects of artemisinin, Artemisia annua extract and control agents on cucumber powdery mildew.

[0114] The above results show that the Artemisia annua extract obtained in Example 1, at a 10-fold dilution (high concentration), has a control effect of up to 70.97% on cucumber powdery mildew, which is significantly better than the 18% D-limonene control agent (control effect 62.90%), indicating that Artemisia annua extract has excellent antibacterial activity at appropriate concentrations.

[0115] Artemisinin monomers exhibit exceptionally high control efficacy against cucumber powdery mildew, with a clear dose-response relationship and strong stability. At a concentration of 100 ppm, the control efficacy reaches 80.65%, significantly exceeding the positive control 18% D-limonene; at a concentration of 500 ppm, the control efficacy reaches as high as 95.16%, with a disease index of only 2.27, almost completely inhibiting disease occurrence. Compared to Artemisia annua extract, artemisinin's efficacy is more stable, reproducible, and has a wider effective concentration window (100-500 ppm), facilitating practical application. Compared to existing plant-derived components (such as D-limonene and terpinene), artemisinin demonstrates stronger inhibitory activity against powdery mildew at the same or lower doses, with lower dosage and more thorough control, showing great potential for development into a highly efficient, low-toxicity, and highly specific bio-based fungicide monomer.

[0116] However, according to existing research data, artemisinin monomers are only effective against powdery mildew and have insufficient effect on other pathogens. This confirms that the Artemisia annua extract obtained in this invention has a broad antibacterial spectrum, while artemisinin monomers are only effective against a specific target.

[0117] The unexpected finding in Table 4 indicates that within the 100-1000 times dilution range of Artemisia annua extract, the control effect did not show a monotonically increasing trend with increasing extract concentration. At a 10-fold dilution, Artemisia annua extract exhibited good control of cucumber powdery mildew, with a control efficacy of up to 70.97%, suggesting that Artemisia annua extract may contain multiple active ingredients exhibiting synergistic or complementary effects at different concentration ranges. This nonlinear dose-response relationship provides a new strategy for developing multi-target, low-residue plant-derived fungicides. Compared to single chemical pesticides, Artemisia annua extract, derived from natural plants, has good environmental compatibility and demonstrates outstanding control efficacy at high concentrations, showing promising prospects for development and application.

[0118] The present invention has been described in detail above. Those skilled in the art will recognize that the invention can be practiced in a wide range of ways with equivalent parameters, concentrations, and conditions without departing from its spirit and scope, and without requiring unnecessary experiments. While specific embodiments have been provided, it should be understood that further modifications can be made to the invention. In summary, according to the principles of the invention, this application is intended to include any changes, uses, or improvements to the invention, including changes made using conventional techniques known in the art that depart from the scope disclosed herein.

Claims

1. The use of Artemisia annua extract or preparations containing Artemisia annua extract in the preparation of products for the prevention and control of plant pathogenic fungi, characterized in that, The Artemisia annua extract is obtained by pulverizing Artemisia annua, adding it to an ethanol-water solution for extraction in the dark, followed by ultrasonic extraction, solid-liquid separation, and concentration of the resulting extract.

2. The use according to claim 1, characterized in that, The plant pathogenic fungus is Fusarium graminearum (Fusarium graminearum). Fusarium graminearum Fusarium oxysporum ( Fusarium oxysporum ), neatly arranged small sclerotia ( Sclerotium rolfsii Rhizoctonia solani ( ), Rhizoctonia solani Rhizoctonia solani ), Cucurbitaceae powdery mildew ( Erysiphe cucurbitacearum ), Tea-seat Discocele ( Discula theae-sinensis ), Camellia thorny spores ( Colletotrichum camelliae ), *Ulva globosum* ( Nigrospora sphaerica ), Dinucleotidylcholine ( Binucleate Rhizoctonia ) Fusion group AG-P, Pseudomonas chamois ( Pseudopestalotiopsis theae ), Curvularia ( Curvularia Fungi, Cercospora ( Cercospora Fungi, Fusarium moniliforme ( Fusarium concentricum ), Subseptospora genus fungi Didymella segeticola At least one of them.

3. The use of Artemisia annua extract or preparations containing Artemisia annua extract in the preparation of products that inhibit the production of deoxynivalenol by Fusarium graminearum, characterized in that, The Artemisia annua extract is obtained by pulverizing Artemisia annua, adding it to an ethanol-water solution for extraction in the dark, followed by ultrasonic extraction, solid-liquid separation, and concentration of the resulting extract.

4. The use according to any one of claims 1-3, characterized in that, The volume fraction of the ethanol-water solution is 70-90%, and the mass-to-volume ratio of Artemisia annua to the ethanol-water solution is 1g:15-25mL.

5. The use according to any one of claims 1-3, characterized in that, The concentration is carried out under reduced pressure; the temperature of the reduced pressure concentration is 30-40℃; the vacuum degree of the reduced pressure concentration is -0.08 to -0.09 MPa.

6. The use according to any one of claims 1-3, characterized in that, The artemisinin content in the Artemisia annua extract is 0.1-0.15% by mass.

7. The use according to any one of claims 1-3, characterized in that, The formulation containing Artemisia annua extract includes Artemisia annua extract and a pharmaceutically acceptable carrier.

8. The use according to any one of claims 1-3, characterized in that, The dosage forms of the preparations containing Artemisia annua extract include, but are not limited to, sustained-release formulations, aqueous solutions, suspensions, emulsions, tablets, powders, granules, and effervescent tablets.

9. A method for inhibiting plant pathogenic fungi, characterized in that, The antibacterial agent containing Artemisia annua extract or an antibacterial agent containing Artemisia annua extract is brought into contact with the plant pathogenic fungus.

10. A method for inhibiting the production of deoxynivalenol by Fusarium graminearum, characterized in that, The antibacterial agent containing Artemisia annua extract or an antibacterial agent containing Artemisia annua extract is brought into contact with the Fusarium graminearum.